ACUT — ACCUSTEM SCIENCES Cashflow Statement
0.000.00%
Last trade - 00:00- $3.13m
- $3.17m
Annual cashflow statement for ACCUSTEM SCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.054 | -0.671 | -3.75 | -2.05 |
| Depreciation | ||||
| Non-Cash Items | 0 | 0.021 | 0.067 | 0.079 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.054 | 0.649 | 1.87 | 0.353 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | 0 | 0 | -1.81 | -1.62 |
| Capital Expenditures | — | — | -0.011 | 0 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | — | — | -0.011 | 0 |
| Financing Cash Flow Items | — | — | 0.205 | 1.25 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | — | — | 2.55 | 0.903 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 0 | 0.734 | -0.713 |